Related Experiment Video
Updated: Jun 6, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Prostate cancer immunology - an update for Urologists
Nieroshan Rajarubendra1, Nathan Lawrentschuk, Damien M Bolton
1Department of Surgery, University of Melbourne, Austin Hospital, Urology Unit, Australia.
BJU International
|November 13, 2010
Summary
Understanding prostate cancer (CaP) immune processes and inflammation is key for new treatments. Immunotherapy, like Sipuleucel-T, shows promise in combating CaP by boosting the immune system.
Area of Science:
- Oncology
- Immunology
- Infectious Diseases
Background:
- Prostate cancer (CaP) progression involves complex immune interactions.
- Tumor escape mechanisms pose a significant challenge for effective CaP treatment.
- Infection and inflammation, potentially linked to xenotropic murine leukemia virus (XMRV), may drive prostate carcinogenesis.
Purpose of the Study:
- To review the role of immune processes in prostate cancer pathogenesis and progression.
- To explore how inflammation and infection influence CaP development and immune surveillance.
- To discuss the potential of immunotherapy in rejuvenating anti-tumor immune responses for CaP.
Main Methods:
- Literature review focusing on the interplay between immunity, inflammation, infection, and prostate cancer.
- Analysis of evidence linking prostate carcinogenesis to inflammatory states and viral agents like XMRV.
- Examination of emerging immunotherapeutic strategies for CaP treatment.
Main Results:
- Inflammatory states can impair immune surveillance and promote a pro-mutagenic environment in prostate cancer.
- Xenotropic murine leukemia virus (XMRV) is a newly identified factor potentially involved in prostate carcinogenesis.
- Sipuleucel-T, an immunotherapy for metastatic castration-resistant prostate cancer, has demonstrated improved survival rates.
Conclusions:
- A deeper understanding of immune processes in CaP pathogenesis is crucial for developing novel therapeutic strategies.
- Immunotherapy offers a promising avenue to enhance anti-tumor immunity and overcome tumor escape mechanisms in prostate cancer.
- The link between prostate cancer, inflammation, and infection warrants further investigation for improved treatment modalities.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...